204 related articles for article (PubMed ID: 7686980)
1. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia.
Barry MJ; Cockett AT; Holtgrewe HL; McConnell JD; Sihelnik SA; Winfield HN
J Urol; 1993 Aug; 150(2 Pt 1):351-8. PubMed ID: 7686980
[TBL] [Abstract][Full Text] [Related]
2. Correlation of transrectal ultrasound measurements of prostate and transition zone size with symptom score, bother score, urinary flow rate, and post-void residual volume.
Terris MK; Afzal N; Kabalin JN
Urology; 1998 Sep; 52(3):462-6. PubMed ID: 9730461
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
4. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
[TBL] [Abstract][Full Text] [Related]
5. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
[TBL] [Abstract][Full Text] [Related]
7. The correlation of multichannel urodynamic pressure-flow studies and American Urological Association symptom index in the evaluation of benign prostatic hyperplasia.
Ko DS; Fenster HN; Chambers K; Sullivan LD; Jens M; Goldenberg SL
J Urol; 1995 Aug; 154(2 Pt 1):396-8. PubMed ID: 7541853
[TBL] [Abstract][Full Text] [Related]
8. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
9. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
[TBL] [Abstract][Full Text] [Related]
10. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
Kaplan SA; Olsson CA; Te AE
J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
12. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score.
Ezz el Din K; Kiemeney LA; de Wildt MJ; Debruyne FM; de la Rosette JJ
Urology; 1996 Sep; 48(3):393-7. PubMed ID: 8804492
[TBL] [Abstract][Full Text] [Related]
13. Experimental treatment of benign prostatic hyperplasia with transurethral balloon dilation of the prostate: preliminary study in 73 humans.
Wasserman NF; Reddy PK; Zhang G; Berg PA
Radiology; 1990 Nov; 177(2):485-94. PubMed ID: 1699247
[TBL] [Abstract][Full Text] [Related]
14. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
[TBL] [Abstract][Full Text] [Related]
15. Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms.
Steele GS; Sullivan MP; Sleep DJ; Yalla SV
J Urol; 2000 Aug; 164(2):344-8. PubMed ID: 10893581
[TBL] [Abstract][Full Text] [Related]
16. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure.
Kaplan SA; Te AE; Pressler LB; Olsson CA
J Urol; 1995 Nov; 154(5):1764-9. PubMed ID: 7563342
[TBL] [Abstract][Full Text] [Related]
17. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup.
Steele GS; Sleep DJ
J Urol; 1997 Nov; 158(5):1834-8. PubMed ID: 9334612
[TBL] [Abstract][Full Text] [Related]
18. Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia.
Kang M; Kim M; Choo MS; Bae J; Ku JH; Yoo C; Oh SJ
Urology; 2014 Dec; 84(6):1461-6. PubMed ID: 25432841
[TBL] [Abstract][Full Text] [Related]
19. Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study.
Kwon O; Lee HE; Bae J; Oh JK; Oh SJ
Urology; 2014 Mar; 83(3):581-5. PubMed ID: 24373317
[TBL] [Abstract][Full Text] [Related]
20. Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms.
Ku JH; Ko DW; Cho JY; Oh SJ
Urology; 2010 Jun; 75(6):1467-71. PubMed ID: 19962734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
